LewRockwell By Megan Redshaw
Children’s Health Defense
A peer-reviewed study in the New England Journal of Medicine shows two doses of an mRNA COVID-19 vaccine yield negative protection against symptomatic SARS-CoV-2 infection, while previous infection without vaccination offers about 50% immunity.
A new peer-reviewed study shows two doses of an mRNA COVID-19 vaccine yield negative protection against symptomatic SARS-CoV-2 infection, while previous infection without vaccination offers about 50% immunity.
The findings, published June 15 in the New England Journal of Medicine (NEJM) analyzed information from more than 100,000 Omicron-infected and non-infected residents in Qatar from Dec. 23, 2021, through Feb. 21, 2022.
The authors compared the effectiveness of the Pfizer and Moderna COVID-19 vaccines, natural immunity from previous infection with other variants and hybrid immunity (a combination of infection and vaccination) against symptomatic Omicron infection and severe, critical and fatal disease.
Daily News PDF Archives – Jellyfish.News